Skip to content
Bomb Report – Lifestyle
Author:
E2M Tech Inc.
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 7, 2026
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 13, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 11, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
E2M Unveils Strategic Rebrand, Introducing the “Black Label Standard” for Digital Agencies
May 6, 2026